Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease - Wikidata - wikimedia - TriplyDB

Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease

Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease

http://www.wikidata.org/entity/Q35869176

about

Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives Novel subcellular localization for α-synuclein: possible functional consequences Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases Reply: Plasma cholesterol and Parkinson's disease: Is the puzzle only apparent?Bridging high-throughput genetic and transcriptional data reveals cellular responses to alpha-synuclein toxicity.Association of fibrinogen with Parkinson disease in elderly Japanese-American men: a prospective study Integrated molecular landscape of Parkinson's disease Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database Serum cholesterol and the progression of Parkinson's disease: results from DATATOP.Statin use and Parkinson's disease in Denmark.Total cholesterol and the risk of Parkinson's disease: a review for some new findings.Serum cholesterol and nigrostriatal R2* values in Parkinson's disease.Transcriptional activation of low-density lipoprotein receptor gene by DJ-1 and effect of DJ-1 on cholesterol homeostasis Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis.Prospects of statins in Parkinson disease Statins, plasma cholesterol, and risk of Parkinson's disease: a prospective study Lanosterol induces mitochondrial uncoupling and protects dopaminergic neurons from cell death in a model for Parkinson's disease.Statin Use and the Risk of Parkinson's Disease: An Updated Meta-Analysis Prospective study of statin use and risk of Parkinson disease.Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease Higher Plasma LDL-Cholesterol is Associated with Preserved Executive and Fine Motor Functions in Parkinson's Disease Dietary cholesterol, fats and risk of Parkinson's disease in the Singapore Chinese Health Study.Targets for neuroprotection in Parkinson's disease Pathogenesis-targeted, disease-modifying therapies in Parkinson disease.Lipid dysfunction and pathogenesis of multiple system atrophy.Parkinson's disease: mitochondrial molecular pathology, inflammation, statins, and therapeutic neuroprotective nutrition.Targeting metabolic inflammation in Parkinson's disease: implications for prospective therapeutic strategies.Cardiovascular disease: primary prevention, disease modulation and regenerative therapy.The ongoing pursuit of neuroprotective therapies in Parkinson disease.The serum lipid profiles of amyotrophic lateral sclerosis patients: A study from south-west China and a meta-analysis.Organophosphate pesticides and PON1 L55M in Parkinson's disease progression.Statins may facilitate Parkinson's disease: Insight gained from a large, national claims database.Confounding of the association between statins and Parkinson disease: systematic review and meta-analysis.The beneficial effects of HMG-CoA reductase inhibitors in the processes of neurodegeneration.Statin use and risk of Parkinson's disease: a meta-analysis of observational studies.Statins reduce neuronal alpha-synuclein aggregation in in vitro models of Parkinson's disease.Statin Use and Its Association with Essential Tremor and Parkinson's Disease.Lovastatin ameliorates alpha-synuclein accumulation and oxidation in transgenic mouse models of alpha-synucleinopathies Circulating Cholesterol Levels May Link to the Factors Influencing Parkinson's Risk Impact of genetic variants of apolipoprotein E on lipid profile in patients with Parkinson's disease

P2860

Q26747508-15E4CC05-854B-4040-B16C-3335A637649D Q26827605-DA7BB785-A4DE-4102-9156-C519389A7AD2 Q27009984-8435960D-ECE5-43FD-A90C-663D4E88A172 Q33348468-57977A3C-9FC6-416C-A2E0-6C8FF175BCFA Q33411281-FBD631D2-E61E-4473-A8A6-39467636F527 Q33637422-3A90237F-8D8F-4B16-9666-FBAEEFB21825 Q33767544-BF259498-4397-4285-9D33-EC7AB7B0A4DA Q33867311-29F3F9AE-ECFD-4839-99AF-A042972D41F8 Q33996828-93CF54A3-0D24-4F19-935A-A5A4B0701064 Q34020626-6C1FC0F6-32C5-413F-B9E0-1ED64F245819 Q34212035-4FDD36F4-2105-4BA9-BA5B-118B028A0BA1 Q34243731-4F295AED-DA4C-4FAB-9EBB-D381221A14E2 Q34292835-07A365DC-B0F4-476F-B8FB-B99EFC703CC9 Q34411415-F46A47C8-67C0-40C2-8509-DEA2668F05EB Q35094028-33DF064A-AB1C-4E81-8B08-E191EC506A7D Q35328089-B5EA99CA-70D6-4BD8-A538-65750737AAAA Q35754683-C30E963C-80E8-43D6-A313-9B2E53D5F75B Q35971467-0D5ADC2C-3AC7-4B09-B453-A2FB6EF0C71E Q36100697-1BF9B1CE-7BBC-49F0-A5FC-1538F9790EA7 Q36667311-8E42B220-A57F-4F41-B041-65F1B00F20D0 Q36983489-D17958AA-DA55-4847-8F5A-5DDD11ABE121 Q37058206-F01D62D1-13C2-4A8F-872D-ECF41A91E679 Q37302453-9DA841C5-2F5D-4B7C-8389-12356381FC10 Q37506492-1667A583-DE9D-46E2-8998-6452451CEF3A Q37580065-4FF34ADD-4432-4ED7-BAB1-AD7D00D4D280 Q37779428-5B3A1BCA-C7E6-4132-A2B7-BE0A8E624D79 Q37962621-A8235BB5-007D-408B-88D3-9A4D7EECC3E4 Q38047290-B8AD0C01-DF96-4562-8F87-5B3CE82A9830 Q38275171-B517045F-31CD-4AD3-B90F-5C0588E9D60D Q38539827-23DB6064-BED2-414B-93DF-B7E08DE37DC6 Q38660920-7DFB539A-806F-4314-B8F7-C04D423649A8 Q38859501-8CB5A758-066C-45D3-AADE-14CC24124FE6 Q38928422-4DCAEFFD-8956-4946-9826-83E53746741A Q39348762-5E4F7ABD-DBB3-47B2-9E5E-FFECA43F7C4B Q39582097-12DC38BA-5A3B-4AA6-9812-D1AAD55386CE Q40016826-9C4478A2-F890-4CAE-8661-1C8DBC0989DF Q40700131-75647D7C-1050-4CF9-9A3C-A400DA76750C Q42078981-BCD7005F-55AF-45D7-AFE8-EB7166F95056 Q42145966-B35A6B4E-2E8C-42A3-99B4-F224BD09085E Q42181761-0D4F1270-E2E7-43BF-9EF1-26DAE838B7A3

P2860

Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease

http://www.wikidata.org/entity/Q35869176

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease

@ast

Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease

@en

type

label

Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease

@ast

Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease

@en

prefLabel

Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease

@ast

Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease

@en

P1433

Q35869176-AF50CAFF-4B43-4CDC-827C-909667B4852E

P1476

Q35869176-7E7B5458-26CF-4408-8C43-5EB69502CEE3

P2093

Q35869176-10AA21E4-68ED-46F3-82F2-F0A6524A6306

Q35869176-13C0456F-1164-4EA0-A513-31816E710098

Q35869176-8063664B-AB99-4E3F-8181-E7BAB6DEC7D6

Q35869176-932092EF-2F05-4CE0-9368-D5539BF27D40

Q35869176-ED04D374-EEF3-4D21-814B-0303FBAEA14E

Q35869176-F5FFB0B0-6B03-4170-968E-5B4C66EC0C2F

P2860

Q35869176-167458E0-442F-49EB-BC2C-D5D2B409D53D

Q35869176-1AEDED56-CA4E-4F77-B954-94DB91D00999

Q35869176-1DEDBCAD-2106-45B0-9FD7-B093BA59A80E

Q35869176-3CE94FCB-64AD-4FA1-A353-6464142F2252

Q35869176-44587053-0175-484B-B0A8-F6F0D6C4AAFD

Q35869176-4621950E-65CF-4063-BB91-45C070751DA1

Q35869176-6A0C0BA4-D442-450E-B547-D976CA265FC5

Q35869176-6D4332AE-CF0B-4C83-B162-2F4E88F74075

Q35869176-751FAE12-0485-4A18-AF70-19E632E795FC

Q35869176-7AF9F3E8-649E-4996-98C8-4A8D89842C9B

P304

Q35869176-B2B33881-357D-4837-AE5E-7DC2D58BEC82

P31

Q35869176-9C6EBEF7-B06C-48B9-B6E1-7B3BAF401719

P356

Q35869176-05F511BA-6B07-4235-830F-5968D8587201

P407

Q35869176-7CED97AF-EB44-4185-95BA-51F301C965E0

P433

Q35869176-B9E4D612-ACB9-4BEE-9B3A-36D8198DAAD4

P478

Q35869176-2E27F6D8-E8C3-47C8-9EFE-5BA00C38C80F

P50

Q35869176-218C7C87-8BF9-4770-83AD-E6C17E311EDF

Q35869176-7C9BF842-6895-4EA2-BEF0-845AAF8926BE

Q35869176-ADCDAE66-9295-49AC-9330-6EF0F25FB97D

Q35869176-BE6806A6-FC6D-436F-907D-44C777B8286F

P577

Q35869176-75EB2C13-E35A-49ED-80DA-F4C07D1D5A96

P5875

Q35869176-A9767339-4BA8-4D88-9EDC-874A5A42D137

P698

Q35869176-32544172-446A-4C51-A9D4-59D26857002B

P921

Q35869176-0B46919E-2E99-4F10-AF7E-1A2E82E8FE7C

Q35869176-51321D96-811D-427C-9BEB-3D3C5895ACFF

Q35869176-A65CC387-F6BC-40BE-A9E0-ABE939149BF8

P932

Q35869176-7EB2A6B8-DF96-478B-9394-ACA611BFEA28

P356

P1433

Movement Disorders

P1476

Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease

@en

P2093

Charles Poole

http://www.w3.org/2001/XMLSchema#string

Dong Xiang

http://www.w3.org/2001/XMLSchema#string

Jennifer L Woodard

http://www.w3.org/2001/XMLSchema#string

Peter C Chen

http://www.w3.org/2001/XMLSchema#string

Richard W Murrow

http://www.w3.org/2001/XMLSchema#string

Yi-Zhe Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Apolipoprotein E: far more than a lipid transport protein

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

APOE-[epsilon]2 allele associated with higher prevalence of sporadic Parkinson disease

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data

Is the cause of Parkinson's disease environmental or hereditary? Evidence from twin studies.

Neuroprotective properties of statins.

Relation of plasma lipids to Alzheimer disease and vascular dementia.

Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease.

Causes of hypocholesterolemia.

P304

377-381

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDS.21290

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

William C Miller

Richard Mailman

P577

2007-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6623361

http://www.w3.org/2001/XMLSchema#string

P698

17177184

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

LDL cholesterol

P932

1906875

http://www.w3.org/2001/XMLSchema#string